Antioxidant / compounded wellness
Prepared by the ezGLP team. Sources last checked .
Also known as Reduced glutathione, GSH
Routes represented in the knowledgebase: Oral / Inhaled / Other / unspecified.
Oral supplement; injectable wellness use is not FDA-approved. FDA has linked compounded IV products to endotoxin reactions and hospitalizations.
No validated PubMed or DOI link is currently curated for this entry.
Serious or important: fever, chills, dizziness, hypotension, and sepsis-like reactions from contaminated compounded IV products.
No established general drug-interaction profile was identified; route and product quality are central.
Safety evidence sourceThese are general, pairwise evidence notes. Green identifies the potential-synergy category, while Lv3/Lv2/Lv1 communicates evidence strength; it does not guarantee benefit or cancel a safety warning.
A small clinical study in early septic shock reported lower lipid-peroxidation markers and improved clinical scores when acetylcysteine was added to glutathione.
Interaction evidence sourceRelated clinical studyFDA sterile-glutathione warningSummarised from published literature for reference only, with citations to the source. Evidence is graded as reported and is not a recommendation to combine, dose, or use any compound.
For personal tracking and education only. Not medical advice, diagnosis, or treatment, and not a medical device. Peptides may be prescription-only or unapproved where you live — consult a licensed healthcare professional.
